Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affordable for low-income Americans. Analysts believe the financial impact on Sun Pharma will be minimal. The company's US revenue contribution is significant, reinforcing its growth strategy. This pact recognizes Sun Pharma's investment in the American market.
The Economic Times
Original source
economic times
Check live status on DownRightNow
1 Top TSX Dividend Stock Down 13% to Buy and Hold for Decades The Motley Fool Canada See more headlines & perspectives on Google News
These newest recipients of the Schulich Leader Scholarship share a passion for shaping a better world through science and engineering.
Delhi revamps solar policy to install 2.3 lakh rooftop systems by 2027, offering free up to 3kW for homes using up to 400 units, with net metering faster.
BJP Cites Migration, AAP Claims BLOs Didn’t Fan Out Properly
Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.
Read Disclaimer